Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heuser

Showing results (101-110 of 280) with videos related to

Pageof 28
Sort By:
Experimental Hematology & Oncology|October 29, 2025
Resolving intra-tumor heterogeneity and clonal evolution of core-binding factor acute myeloid leukemia patients with single-cell resolutionRaphael Hablesreiter, Paulina M Strzelecka, Klara Kopp, et al.
Leukemia|March 28, 2025
XPO1-dependency of DEK::NUP214 leukemiaFiorella Charles Cano, Arnold Kloos, Rucha Y Hebalkar, et al.
Leukemia|December 15, 2018
Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemiaMichaela Scherr, Hanna Kirchhoff, Karin Battmer, et al.
Hemasphere|October 7, 2022
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative AnalysisNico Gagelmann, Rachel B Salit, Thomas Schroeder, et al.
Annals of Hematology|August 28, 2013
Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemiaGesine Bug, Steffen Koschmieder, Juergen Krauter, et al.
Blood|March 19, 2010
Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3Bob Argiropoulos, Eric Yung, Ping Xiang, et al.
International Journal of Molecular Sciences|September 23, 2022
Healthy-like CD4<sup>+</sup> Regulatory and CD4<sup>+</sup> Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte InfusionJessica Schneider, Leonie Kuhlmann, Yankai Xiao, et al.
Current Cancer Drug Targets|June 21, 2016
Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug ScreeningAmit Sharma, Nidhi Jyotsana, Courteney K Lai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2016
Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector PlatformJuwita Hübner, Shahabuddin S Hoseini, Julia D Suerth, et al.
RNA (New York, N.Y.)|August 6, 2016
Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulatorsJinsong Qiu, Bing Zhou, Felicitas Thol, et al.
Pageof 28

Showing results (101-110 of 280) with videos related to

Sort By:
Pageof 28
Experimental Hematology & Oncology|October 29, 2025
Resolving intra-tumor heterogeneity and clonal evolution of core-binding factor acute myeloid leukemia patients with single-cell resolutionRaphael Hablesreiter, Paulina M Strzelecka, Klara Kopp, et al.
Leukemia|March 28, 2025
XPO1-dependency of DEK::NUP214 leukemiaFiorella Charles Cano, Arnold Kloos, Rucha Y Hebalkar, et al.
Leukemia|December 15, 2018
Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemiaMichaela Scherr, Hanna Kirchhoff, Karin Battmer, et al.
Hemasphere|October 7, 2022
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative AnalysisNico Gagelmann, Rachel B Salit, Thomas Schroeder, et al.
Annals of Hematology|August 28, 2013
Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemiaGesine Bug, Steffen Koschmieder, Juergen Krauter, et al.
Blood|March 19, 2010
Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3Bob Argiropoulos, Eric Yung, Ping Xiang, et al.
International Journal of Molecular Sciences|September 23, 2022
Healthy-like CD4<sup>+</sup> Regulatory and CD4<sup>+</sup> Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte InfusionJessica Schneider, Leonie Kuhlmann, Yankai Xiao, et al.
Current Cancer Drug Targets|June 21, 2016
Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug ScreeningAmit Sharma, Nidhi Jyotsana, Courteney K Lai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2016
Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector PlatformJuwita Hübner, Shahabuddin S Hoseini, Julia D Suerth, et al.
RNA (New York, N.Y.)|August 6, 2016
Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulatorsJinsong Qiu, Bing Zhou, Felicitas Thol, et al.
Pageof 28